Antithymocyte

基本解釋

Objective To observe the effect of antithymocyte globulin(ATG) on kidney transplantation rejection.
目的觀察抗胸腺細胞球蛋白(ATG)預防及治療腎移植排斥反應的效果。
Antithymocyte globulin (ATG) is employed for the treatment and prevention of acute organ rejection after transplantation.
抗胸腺細胞球蛋白（ATG）被用來治療和預防器官移植后的急性排斥反應。
Pretreatment of patients consisted of a combination of antithymocyte globulin, cyclophosphamide, and low-dose total body irradiation.
預處理方案為聯(lián)合使用環(huán)磷酰胺、抗胸腺球蛋白和小劑量全身照射。
Immunotherapy with either antithymocyte globulin (ATG) or antilymphocyte globulin (ALG) is the primary treatment for those children not candidates for bone marrow transplant.
采用抗胸腺細胞球蛋白（ATG）或抗淋巴細胞球蛋白（ALG）免疫療法是不適宜于骨髓移植患兒的主要治療方法。
Abstract：Immunosuppression for immunologically high-risk renal transplant patients usually inoles antithymocyte globulin induction with triple drug maintenance therapy.
摘要:腎移植免疫高危患者的免疫抑制方案通常是予抗胸腺細胞球蛋白誘導免疫抑制;然后以三聯(lián)免疫抑制藥物維持治療.